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Prevalence and risk factors for canine epilepsy 
of unknown origin in the UK
L. Kearsley-Fleet, D. G. O’Neill, H. A. Volk, D. B. Church, D. C. Brodbelt
Epidemiological evaluation of canine epilepsy is an under-researched area. The objectives of 
this study were to estimate prevalence and investigate risk factors for epilepsy of unknown 
origin (EUO) among dogs attending primary veterinary practices in the UK. The clinical data 
analysed spanned a two-year period and included all dogs attending 92 primary veterinary 
clinics participating in the VetCompass project. Five hundred and thirty-nine EUO cases were 
identified giving a prevalence of 0.62% (95% CI 0.57% to 0.67%). Males were over 1.5 times 
as likely to have EUO compared with females (95% CI 1.44 to 2.06; P<0.001). Of purebred 
dogs, the border terrier had 2.70 (95% CI 1.57 to 4.62; P<0.001) and the German shepherd 
dog had 1.90 (95% CI 1.28 to 2.80; P=0.001) times increased odds of EUO compared with 
crossbred dogs. In addition, the West Highland white terrier had reduced odds (OR 0.23; 
95% CI 0.08 to 0.62; P=0.004) of EUO compared with crossbred dogs (likelihood ratio test 
P<0.0001). No association was found with neuter status, colour or weight. The current study 
highlights the clinical importance of epilepsy as a canine disorder in the UK. Increased 
awareness of sex and breed predispositions may assist clinicians with diagnosis. Further 
research is merited to evaluate the specific breed associations identified.
Introduction
Epilepsy is the most common chronic neurological disorder in human 
beings with an estimated worldwide incidence of approximately 
0.05–0.1 per cent, and a prevalence of 0.4–1 per cent (Sander and 
Shorvon 1996, Cowan 2002). Epilepsy in dogs has also been suggest-
ed to be the most common chronic neurological condition (Chandler 
2006, Fluehmann and others 2006) with an estimated prevalence of 
1–2 per cent in a referral hospital population (Schwartz-Porsche 1986). 
The exact prevalence of epilepsy in the general dog population, how-
ever, remains unknown.
Recently, individual breed and country-specific prevalence of 
canine genetic epilepsy have been estimated ranging from 0.7 per cent 
to 18.3 per cent (Jaggy and others 1998, Kathmann and others 1999, 
Berendt and others 2002, 2008, Casal and others 2006, Gullov and 
others 2011). Despite reports showing a higher risk of epilepsy in cer-
tain breeds, there remains a lack of epidemiological studies estimating 
prevalence and investigating risk factors for epilepsy in general dog 
populations. Short and others (2011) have investigated associations 
between sex and neuter status with treated cases of epilepsy, but did 
not statistically evaluate breed effects. Idiopathic epilepsy (IE) has also 
been seen more frequently in solid coat-colour Cavalier King Charles 
spaniels indicating that the number of colours may have some asso-
ciation with the disease (Rusbridge 2005). The current study aimed 
to investigate the prevalence and risk factors for canine epilepsy of 
unknown origin (EUO) in the UK in general practice in order to better 
understand the clinical importance of the disorder.
Materials and methods
Study data were collected within VetCompass Animal Surveillance 
(Vetcompass 2011), an ongoing Royal Veterinary College (RVC) pro-
ject sharing first-opinion clinical data with UK veterinary practices 
via Practice Management Systems (PMSs). Participating practices rou-
tinely recorded electronic patient records and, additionally, selected 
the most appropriate summary diagnostic terms from an embedded 
list of standard terminology, the VeNom codes (Venom Coding Group 
2011), at the end of each episode of clinical care. Data were uploaded 
from the PMSs of participating practices to the VetCompass data-
base. Ethics approval was obtained from the RVC Ethics and Welfare 
Committee (URN 20101076a).
The diagnosis of EUO was based on a history of more than two 
seizures in the absence of other medical problems and a history of 
seizures for more than one year, or four or more separate repeat antie-
pileptic drug prescriptions (in the absence of evidence of their use for 
any purpose other than seizure control). Absence of other medical 
problems was confirmed for all affected dogs by unremarkable clini-
cal examination results, complete blood count and serum biochemical 
analysis. Identified patients were excluded if the records reported evi-
dence of an underlying disease that could have caused epilepsy, includ-
ing advanced brain imaging abnormalities, or there was insufficient 
information on the chronicity of the disease.
All purebred names and groups were established using the Kennel 
Club (KC) database (UK Kennel Club 2011). Values from the earli-
est consultation with a diagnosis of EUO were used for weight, 
while values from the earliest overall observation were included for 
 non-EUO cases. Age and neuter status were taken from the last record 
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of each dog. The risk factors investigated were sex, neuter status, 
breed, purebred status, purebred KC group, purebred KC size category, 
purebred KC coat length, coat-colour and weight with age included as 
a potential confounder.
Data analysis
Data were imported into Microsoft ExcelI for cleaning before being 
analysed using the statistical software StataII. Data cleaning includ-
ed data entry checks, standardisation of breed and other factors and 
consolidation of the data into one unique record per dog. Descriptive 
statistics were generated for the overall population of EUO dogs. 
Univariable risk factor analysis was performed on all variables to 
evaluate an association with EUO with χ2 and Fisher’s exact tests 
for categorical, and the unpaired t test and Mann-Whitney U test for 
continuous data, respectively. Mixed-effects logistic regression mod-
els using the ‘xtmelogit’ command were constructed accounting for 
clustering at the veterinary clinic level. Risk factors with a liberal uni-
variable association with the outcome (P<0.15) were carried forward 
for multivariable analysis (Dohoo and others 2010). Model building 
followed a manual forward stepwise construction process using the 
likelihood ratio test. Final model variables were assessed for pairwise 
interactions. The ‘quadchk’ command was performed to assess clinic 
as a random effect, and the final model fit was evaluated with the 
Hosmer-Lemeshow goodness-of-fit test. Statistical significance was 
set at the 5 per cent level.
Results
Ninety-two UK veterinary practices contributed data relating to 
87,317 dogs with a total of 680,322 observations between January 
2010 and April 2011. Forty-eight percent of all dogs were female (95% 
CI 47.3% to 48.0%), 53.0% (95% CI 52.7% to 53.4%) were neutered 
and 20.1% (95% CI 19.8% to 20.4%) were crossbreds. The most com-
mon dog breeds were the labrador retriever (9.8 per cent), Staffordshire 
bull terrier (7.8 per cent), Parsons (Jack) Russell terrier (7.1 per cent) 
and cocker spaniel (4.0 per cent). The most common KC breed groups 
were the terrier group (22.2 per cent), gundogs (21.4 per cent), toy 
group (10.7 per cent) and pastoral (8.5 per cent). Of KC purebreds, 
20.2 per cent and 27.4 per cent were small and large-sized, respec-
tively, and 44.2 per cent and 7.4 per cent were short and long-haired. 
Many (42.6 per cent) of the dogs were solid coat-colour; 11.6 per cent 
were black and 11.4 per cent were red-golden, while 37.4 per cent of 
dogs were two-tone in colour and 19.9 per cent were multicoloured. 
Of the 99.5 per cent of dogs with age data, 38.3 per cent of dogs were 
older than six years at the final record available.
Five hundred and thirty-nine cases met the inclusion criteria, giv-
ing an EUO prevalence of 0.62% (95% CI 0.57% to 0.67%). Overall 
among cases, 2.2 per cent had undergone an MRI scan and 87.8 per 
cent received long-term antiepileptic medication. The majority of 
EUO dogs on treatment were prescribed monotherapy during the 
study period (83.7 per cent), though 15.4 per cent received two and 
0.9 per cent received three or more therapies (Table 1). Phenobarbitone 
was the major drug prescribed, with approximately 96 per cent of 
EUO dogs receiving it, while potassium bromide, either prescribed 
on its own or with phenobarbitone, was prescribed for 18 per cent of 
cases.
Analysis of risk factors
Univariable risk factor analysis identified males, and neutered dogs 
appeared at increased odds of EUO (Table 2). Individual breeds also 
appeared at increased odds of EUO, though purebred dogs (as a group) 
versus crossbred dogs were not statistically significant in the univari-
able analysis. Heavier dogs were statistically significantly associated 
with presence of EUO, as were short coat length and certain coat col-
ours in purebred dogs.
In the multivariable analysis, sex, breed and age at consultation 
were statistically significantly associated with presence of EUO 
(Table 3). Male dogs had 1.72 times the odds (95% CI 1.44 to 2.06; 
P<0.001) of EUO compared with females. However, there was no 
I Microsoft Corporation. Microsoft Office 2010. Redmond, Washington.
II StataCorp. 2011. Stata Statistical Software: Release 12. College Station, TX: StataCorp LP.
evidence of an association between neuter status and EUO. Among 
specific breeds, the border terrier had 2.70 (95% CI 1.57 to 4.62; 
P<0.001) and the German shepherd dog 1.90 (95% CI 1.28 to 2.80; 
P=0.001) times the odds of EUO compared with crossbred dogs. The 
West Highland white terrier had reduced odds of 0.23 (95% CI 0.08 
to 0.62; P=0.004) of EUO compared with crossbred dogs. Dogs aged 
between 3.01 years and 6.00 years had 0.58 (95% CI 0.46 to 0.73; 
P<0.001) times the odds of EUO compared with dogs aged 
10.01 years or older.
No final model pairwise interactions were detected, and clin-
ic attended was retained in the final model as a random effect 
(P=0.0017). The Hosmer-Lemeshow test suggested good model fit 
(P=0.8552).
Discussion
(Jaggy and others 1998, Kathmann and others 1999, Berendt and 
others 2002, 2008, Casal and others 2006, Gullov and others 2011). 
This retrospective study identifies EUO as an important disorder 
among dogs with a clinically relevant prevalence of 0.62 per cent. The 
study highlights sex and breed as a major risk factors for the disorder. 
Consistent with previous work, male dogs were at increased odds of 
having the condition. German shepherd dogs and border terriers were 
identified as associated with increased odds of the condition, while 
West Highland white terriers showed reduced odds of EUO.
Previous work has reported a wide range of prevalence of IE 
of between 0.7 per cent and 18 per cent (Jaggy and others 1998, 
Kathmann and others 1999, Berendt and others 2002, 2008, Casal 
and others 2006, Gullov and others 2011). These studies related to 
individual breeds and specific countries, and the current work suggests 
the prevalence in the UK veterinary primary practice attending popu-
lation is likely to be at the lower end of this range. The treatments 
administered were consistent with previous work in the UK (Short 
and others 2011), with phenobarbitone representing the major drug 
used for therapy. Interestingly, a small but still clinically relevant num-
ber of dogs were additionally or solely treated with potassium bro-
mide, suggesting that for a number of dogs, phenobarbitone therapy 
did not appear to adequately control the seizures.
The finding that male dogs were at increased odds of EUO com-
pared with female dogs is consistent with previous epidemiological 
work on IE from Short and others (2011) (OR 1.64; 95% CI 1.42 to 
1.89). Several breed-specific studies have also reported an over-repre-
sentation of male dogs (Bielfelt and others 1971, Srenk and others 
1994, Kathmann and others 1999, Patterson and others 2005, Casal 
and others 2006, Gullov and others 2011). It has been suggested that 
IE is an autosomal recessive trait, according to the results of a study by 
Casal and others (2006), with a tendency for increased risk in male 
dogs, though this work relates to one breed only, and hence, the genet-
ic basis may be of limited relevance to the wider canine population.
In the current study, neuter status was not shown to be associ-
ated with EUO, in agreement with several studies (Berendt and others 
2002, 2008), but contradicting the findings of Short and others (2011) 
(OR 1.59; 95% CI 1.37 to 1.85). Short and others (2011) speculated 
that their findings might have been biased by reverse causality where 
dogs with epilepsy were then neutered due to the belief that neutering 
improved seizure control. The lack of an association between neuter-
TABLE 1:  Drug therapy protocols prescribed to cases of canine 
epilepsy of unknown origin that received medical therapy 
among 92 primary veterinary clinics
Prescription Frequency (%)
Phenobarbitone only 376 (79.5)
Potassium bromide only 17 (3.6)
Gabapentin only 1 (0.2)
Levetiracetam only 2 (0.4)
Phenobarbitone and potassium bromide 68 (14.4)
Phenobarbitone and gabapentin 1 (0.2)
Phenobarbitone and levetiracetam 3 (0.6)
Potassium bromide and Levetiracetam 1 (0.2)
Phenobarbitone and levetiracetam and Potassium bromide 4 (0.9)
Dogs treated* 473 (100)
*87.8 per cent (473/539) were treated with antiepileptic medication
 group.bmj.com on January 9, 2013 - Published by veterinaryrecord.bmj.comDownloaded from 
Paper
10.1136/vr.101133 | Veterinary Record | 3 of 5
ing and EUO in the current study suggests any biological association 
may be minor.
Though purebred dogs per se did not appear at increased odds of 
EUO compared with crossbreds, the current study identified specific 
individual breeds at increased odds of the disease. This is consistent 
with previous work evaluating breed associations with IE (Chandler 
2006, Seppala and others 2012). This study reinforces evidence for an 
increased risk of EUO in the German shepherd dog (Falco and oth-
ers 1974) and border terrier (Kloene and others 2008). Increased odds 
of EUO in certain purebred dogs may result from decreasing genetic 
diversity resulting from selective breeding used to maintain purebred 
characteristics. Interestingly, the West Highland white terrier was 
associated with reduced odds of EUO. This has not previously been 
reported. To date, most studies of canine IE have related to specific dog 
breeds with poor generalisation to the wider dog population.
In a recent study of canine epilepsy in the UK, Short and others 
(2011) suggested that the border collie and Staffordshire bull terrier were 
at greater risk of developing epilepsy by comparing epilepsy cases with 
annual registration figures with the KC. The cross-sectional nature of 
their study and the inclusion of only treated epileptic dogs compared 
TABLE 2: Results of univariable mixed effects logistic regression analysis (clinic ID as random effect) of individual risk factors for canine 
epilepsy of unknown origin among 92 primary veterinary clinics
Variable Category OR Case Non-cases 95% CI P value
Sex Female 1 (base) 190 41416
Male 1.69 348 44955 1.42 to 2.02 <0.0001
Neuter status Entire 1 (base) 207 40807
Neutered 1.41 332 45971 1.19 to 1.69 0.0001
Purebred status Crossbred 1 (base) 93 17452
Purebred 1.21 446 69326 0.97 to 1.52 0.0946
Most common purebreds Crossbred 1 (base) 93 17452
Border collie 1.61 23 2664 1.02 to 2.55
Border terrier 2.89 16 1060 1.69 to 4.93
Boxer 1.38 10 1343 0.71 to 2.65
Cavalier King Charles spaniel 0.95 11 2155 0.51 to 1.78
German shepherd dog 2.12 36 3182 1.44 to 3.12
Parson ( Jack) Russell terrier 1.36 44 6130 0.95 to 1.95
Golden retriever 1.89 19 1874 1.15 to 3.11
Labrador retriever 1.51 68 8510 1.10 to 2.07
Cocker spaniel 1.16 21 3430 0.72 to 1.87
Staffordshire bull terrier 0.67 24 6803 0.43 to 1.05
Yorkshire terrier 0.79 12 2850 0.43 to 1.44
English springer spaniel 0.68 7 1914 0.32 to 1.47
West Highland white terrier 0.29 4 2550 0.11 to 0.79
Remaining purebred 1.15 151 24861 0.89 to 1.49 <0.0001
KC purebred group Crossbred 1 (base) 93 17452
Gundog 1.45 142 18501 1.11 to 1.88
Hound 1.47 28 3600 0.96 to 2.25
Pastoral 1.83 72 7350 1.34 to 2.49
Terrier 0.99 101 19257 0.75 to 1.32
Toy 1.11 55 9290 0.80 to 1.56
Utility 0.82 28 6451 0.53 to 1.25
Working 0.77 20 4877 0.47 to 1.25 <0.0001
KC purebred size Crossbred 1 (base) 93 17452
Small 1.09 101 17509 0.82 to 1.44
Medium 1.05 157 28120 0.82 to 1.36
Large 1.49 188 23697 1.16 to 1.91 0.0017
KC purebred coat-length Crossbred 1 (base) 93 17452
Short 1.31 266 38288 1.04 to 1.67
Medium 1.17 154 24577 0.90 to 1.52
Long 0.76 26 6461 0.49 to 1.17 0.0138
Coat-colour type Solid 1.01 238 36987 0.80 to 1.26
Two-tone 0.91 190 32496 0.72 to 1.15
Multicoloured 1 (base) 111 17295 0.5696
Coat colours Black 1 (base) 60 10078
White-cream 0.63 25 6660 0.39 to 1.01
Brown 1.14 59 8802 0.79 to 1.63
Red-golden 1.42 83 9837 1.02 to 1.98
Blue-grey 1.15 11 1610 0.60 to 2.19
Two-tone 0.98 190 32496 0.73 to 1.32
Multicoloured 1.08 111 17295 0.79 to 1.48 0.0171
Age (continuous) Age 1.14 1.12 to 1.16* <0.0001
Age ≤0.50 years 0.01 1 9163 0.01 to 0.07
0.51–3.00 years 0.15 42 25070 0.11 to 0.22
3.01–6.00 years 0.59 123 19222 0.47 to 0.74
6.01–10.00 years 1.07 204 17474 0.87 to 1.31
10.01–18.00 years 1 (base) 169 15373 <0.0001
Weight (continuous) Weight 1.01 1.01 to 1.02 <0.0001
Weight ≤5.00 kg 1 (base) 18 5894
5.01–10.00 kg 2.23 77 11324 1.34 to 3.73
10.01–15.00 kg 2.64 52 6441 1.54 to 4.52
15.01–20.00 kg 2.02 32 5194 1.12 to 3.61
20.01–30.00 kg 2.47 73 9683 1.47 to 4.15
30.01–40.00 kg 3.73 67 5833 2.21 to 6.30
>40.00 kg 4.62 31 2177 2.58 to 8.29
Unknown 1.52 189 40232 0.93 to 2.47 <0.0001
Cases were EUO dogs, non-cases were dogs presented to practice without evidence of EUO
EUO, Epilepsy of unknown origin; KC, Kennel Club
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with laboratory-based controls derived from a genetic database meant 
it may have been prone to selection bias (Short and others 2011). The 
current investigation aimed to reduce selection bias by ensuring that 
both cases and non-cases were representative of the target population. 
The study sampled the entire vet-visiting population that included over 
87,000 dogs from 92 veterinary clinics in the UK, and all dogs with 
data recorded were included.
There were some limitations to this study. The study dataset 
included both pre-existing and incident cases, reducing the value of 
age at consultation as a predictive factor. The age values used in the 
analysis related to the final age recorded in the dataset which, while 
consistent between case and non-case dogs, gave no indication of age 
of onset. Age was included in the model primarily to control for its 
potential confounding effect rather than to generate information on 
age as a risk factor. A cohort of longer duration would be required 
to investigate the age at first diagnosis of EUO in incident cases. 
Case identification relied strongly on veterinarian clinical acumen 
and diagnostic resources. Some EUO cases may have been missed 
due to unusual, mild or infrequent clinical signs leading to under-
reporting. Additionally, due to limited financial and clinical resourc-
es, it is possible that some cases of EUO were incorrectly diagnosed 
as such due to an inability to undertake more in-depth diagnostic 
procedures to identify underlying primary disease. Among the 539 
cases in this study, just 2.2 per cent were noted to have received 
an MRI examination in the study period, and only 0.9 per cent of 
EUO dogs aged over six years underwent an MRI examination. It 
is possible that some of the older dogs could have had undetected 
intracranial pathology. In a recent study of dogs with epilepsy, only 
2.2 per cent of dogs with a normal interictal neurological exam had 
brain changes visible on MRI when they were less than six years 
of age, whereas 26.7 per cent had abnormal MRI findings when 
older than six years of age (Smith and others 2008). However, it is 
possible that the level of MRI examination was underestimated in 
the current study because some dogs could have had an MRI prior 
to the study period that was not noted in the records. Nonetheless, 
despite the potential for misclassification of disease, this remains a 
valuable estimate of the prevalence of EUO in a broad, first-opinion, 
veterinary practice population.
Mixed-effects modelling accounted for the clustering effects of 
veterinary clinic within the data as it was likely there might be vari-
ation between clinics in the diagnosis and treatment of the disease. 
Multivariable modelling adjusted for known measurable confounders, 
in particular, age at consultation. However, there may have been other 
confounding variables to consider. Insurance status of the dog may 
impact on the likelihood of a diagnosis of EUO (Egenvall and  others 
2009). Insured dogs may be more thoroughly worked up because 
financial constraints are less limiting. Owner socioeconomic status 
may also confound the outcome. In human beings, there is evidence 
of association between socioeconomical status and hospitalisation 
for epilepsy (Li and others 2008). Postcode data (available with the 
VetCompass dataset) could be used to explore an association between 
an owner’s socioeconomic status and EUO in future studies. In addi-
tion, ArcGIS mapping could be performed with these postcodes to 
investigate evidence for case clustering. History of another dog or 
family member with epilepsy may also be a confounder, as past events 
may influence present decisions on further treatment, investigation or 
euthanasia.
Conclusion
This large retrospective study describes an epidemiological approach 
to the study of prevalence and risk factors for EUO among dogs in 
the UK. In this study, EUO prevalence was found to be 0.62 per cent. 
Risk factors associated with EUO included sex and breed, with strong 
evidence that male dogs were at increased odds of EUO compared 
with female dogs. The current study reinforces evidence for associa-
tion between the German shepherd dog and border terrier breeds with 
EUO, and highlights a previously unreported finding of a reduced 
odds of EUO in West Highland white terriers. While certain breeds 
appeared at increased odds of EUO, overall purebred dogs, in general, 
were not found to be at a greater odds of the disease compared with 
crossbred dogs. A cohort of longer duration is needed to assess inci-
dent cases and progression of the disease, while repeat analysis of the 
expanding VetCompass dataset would increase power to evaluate 
other breed effects.
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